English
Caplin Point Laboratories Q2 Results
- BSE: 524742
- NSE: CAPLIPOINT
- ISIN: INE475E01026
- Sector: Biotechnology & Drugs
BSE
1,932.00
-23.45 (-1.20%)
-23.45 (-1.20%)Volume630.00
Updated: Tue 16 Dec, 2025 | 15:29:44
NSE
1,945.60-10.00 (-0.51%)
-10.00 (-0.51%)Volume26.23 K
Updated: Tue 16 Dec, 2025 | 15:40:36
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹534.04 Cr.(10.54%)
- Operating Profit₹170.77 Cr.(15.39%)
- Profit After Tax₹154.45 Cr.(18.08%)
- Operating Margin31.98%(4.38%)
Note: Comparison is on YoY basis
Quarterly - Caplin Point Laboratories Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 363.27 | 348.75 | 4.16% | 335.10 | 8.41% |
| Depreciation/ Amortization | 18.40 | 16.29 | 12.95% | 16.76 | 9.79% |
| Operating Income | 170.77 | 161.47 | 5.76% | 148.00 | 15.39% |
| Net Income | 154.45 | 152.80 | 1.08% | 130.80 | 18.08% |
| Other Operating Expenses Total | 87.34 | 94.06 | -7.14% | 85.23 | 2.48% |
| Net Income Before Taxes | 201.00 | 184.46 | 8.97% | 168.46 | 19.32% |
| Total Revenue | 534.04 | 510.22 | 4.67% | 483.10 | 10.54% |
| Selling/ General/ Admin Expenses Total | 47.23 | 43.16 | 9.43% | 44.29 | 6.64% |
| Diluted Normalized EPS | 20.25 | 20.03 | 1.10% | 17.12 | 18.28% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.